这家上市公司这样发公告，该不该遭谴责？如何让公告更有温度？

Core Viewpoint - Nanhua Biological's recent announcements have created confusion among investors, with an optimistic annual performance forecast followed by a stark risk warning about potential delisting, highlighting the contrasting nature of the information provided [1][2]. Group 1: Regulatory Compliance and Information Disclosure - The initial performance forecast presented a balanced view, showcasing potential revenue growth while also acknowledging uncertainties and delisting risks, thus serving as a responsible communication to investors [2][4]. - The subsequent risk warning is a regulatory requirement aimed at ensuring that all investors are aware of the potential for delisting, regardless of previous optimistic announcements [2][3]. - This approach reflects a regulatory logic that prioritizes investor awareness of risks, especially for companies on the brink of delisting [3]. Group 2: Investor Perception and Market Behavior - Investors may feel a sense of unfairness due to the lack of positive mentions in the risk warning, but this is a deliberate regulatory strategy to combat selective attention and speculative behavior in the market [4][5]. - The regulatory framework aims to isolate risks rather than obscure information, emphasizing the importance of recognizing the worst-case scenarios before considering any positive news [5]. Group 3: Suggestions for Improvement in Information Disclosure - There is a call for enhancing the effectiveness of information disclosure beyond mere compliance, suggesting that risk warnings should include contextual links to related announcements to aid investor understanding [6][7]. - Implementing a mandatory index of related announcements in significant disclosures could help investors piece together a comprehensive view of the company's situation [7]. Group 4: Conclusion on Nanhua Biological's Actions - Nanhua Biological should not be criticized for its actions, as it is adhering to existing regulatory frameworks and fulfilling its obligations responsibly [8]. - There is a need for a more intelligent and considerate regulatory approach that respects investor comprehension while maintaining robust risk warnings [8].